In 2019, Professor Lynne Emmerton led the review of name similarity for:

• Monoclonal antibodies (MABs) (commonly ending in the suffix ‘mab’)
• Tyrosine kinase (factor) inhibitors (TKIs) (commonly ending in the suffix ‘nib’).

This included the theoretical risk of confusion within these classes of medicines in clinical practice, including the similarity in clinical indication, with a view to producing a specialised list of medicines. The results of this review can be found in this publication.

The purpose of this fact sheet is to help cancer patients, their families, carers or volunteers understand what to expect from a health service providing people with medications for cancer.

This issue includes items on patient safety practices, potentially preventable readmissions, patient and family engagement, transitions of care, homelessness, medication safety, medication reconciliation and Hepatitis C virus and more.

Also covered is the latest issue of Public Health Research & Practice along with the latest online papers from BMJ Quality & Safety and the International Journal for Quality in Health Care and the latest from the UK’s NICE.

Technical note on the antimicrobial medicines dispensing report 2013-14 to 2017-18.